Impact of a New Formulation of Low-Dose Micronised Medroxyprogesterone and 17-β Estradiol on Lipid Profiles in Menopausal Women

被引：0
|
作者：
R. F. Harrison
P. Magill
S. G. Kilminster
机构：
[1] Royal College of Surgeons of Ireland,Academic Department of Obstetrics and Gynaecology
[2] Rotunda Hospital,Nuffield Department of Obstetrics and Gynaecology, The Women’s Centre
[3] Oxford Radcliffe Hospitals,Department of Cardiological Sciences
[4] St George’s Hospital Medical School,undefined
来源：
Clinical Drug Investigation | 1998年 / 16卷
关键词：
Cholesterol; Adis International Limited; High Density Lipoprotein; High Density Lipoprotein Cholesterol; Medroxyprogesterone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To evaluate the impact of cyclical low-dose micronised medroxyprogesterone (5 mg/day for the last 12 days of each 28-day cycle) in combination with 17-β estradiol (2 mg/day continuously) on lipid profiles in postmenopausal women treated for 12 months.
引用
收藏
页码：93 / 99
页数：6
相关论文
共 34 条
  • [1] Impact of a new formulation of low-dose micronised medroxyprogesterone and 17-β estradiol on lipid profiles in menopausal women
    Harrison, RF
    Magill, P
    Kilminster, SG
    [J]. CLINICAL DRUG INVESTIGATION, 1998, 16 (02) : 93 - 99
  • [2] Efficacy and safety of a new, low-dose estradiol acetate formulation for menopausal symptoms
    Ellman, H
    Gilbert, RD
    Haney, AF
    [J]. OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 63S - 63S
  • [3] PHARMACOKINETIC STUDIES ON LOW-DOSE ESTRADIOL 17-BETA ADMINISTERED ORALLY TO POST-MENOPAUSAL WOMEN
    SIPINEN, S
    LAHTEENMAKI, P
    LUUKKAINEN, T
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1980, 59 (02) : 149 - 153
  • [4] Low-dose estradiol and endothelial and inflammatory biomarkers in menopausal overweight/obese women
    da Silva, L. H. A.
    Panazzolo, D. G.
    Ferreira Marques, M.
    Souza, M. G. C.
    Dias Paredes, B.
    Nogueira Neto, J. F.
    Leao, L. M. C. S. M.
    Morandi, V.
    Bouskela, E.
    Kraemer-Aguiar, L. G.
    [J]. CLIMACTERIC, 2016, 19 (04) : 337 - 343
  • [5] Effects of low-dose 17-β-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women
    Kaleli, B
    Yildirim, B
    Demir, S
    Alatas, E
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (12) : 1107 - 1111
  • [6] Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17β-estradiol and norethisterone acetate
    Samsioe, G
    Li, CR
    Borgfeldt, C
    Wilawan, K
    Åberg, A
    Larsen, S
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2002, 9 (05): : 335 - 342
  • [7] THE EFFECT OF LOW-DOSE PIPERAZINE ESTRONE SULFATE AND LOW-DOSE LEVONORGESTREL ON BLOOD LIPID-LEVELS IN POST-MENOPAUSAL WOMEN
    WREN, B
    GARRETT, D
    [J]. MATURITAS, 1985, 7 (02) : 141 - 146
  • [8] Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women
    Gambacciani, M
    Ciaponi, M
    Cappagli, B
    Monteleone, P
    Benussi, C
    Bevilacqua, G
    Genazzani, AR
    [J]. MATURITAS, 2003, 44 (02) : 157 - 163
  • [9] Impact of preimplantational oral low-dose estradiol-17 exposure on the endometrium: The role of miRNA
    Floeter, Veronika L.
    Lorenz, Anne-Kathrin
    Kirchner, Benedikt
    Pfaffl, Michael W.
    Bauersachs, Stefan
    Ulbrich, Susanne E.
    [J]. MOLECULAR REPRODUCTION AND DEVELOPMENT, 2018, 85 (05) : 417 - 426
  • [10] Improvement of quality of life and menopausal symptoms in climacteric women treated with low-dose monthly parenteral formulations of non-polymeric microspheres of 17β-estradiol/progesterone
    Cortes-Bonilla, Manuel
    Alonso-Campero, Rosalba
    Bernardo-Escudero, Roberto
    Francisco-Doce, Maria T.
    Chavarin-Gonzalez, Juan
    Perez-Cuevas, Ricardo
    Chedraui, Peter
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (10) : 831 - 834
1234